Immuno-Oncology NewsResearchers Develop Guidelines for Management of CAR T-cell Triggered ToxicitiesImmuno-Oncology NewsResearchers have developed guidelines for handling the potentially fatal side effects of CAR T-cell therapy, which along with its un… Continue reading
FierceBiotech |
News of Note—Gene therapy to restore sight; umbilical cord cells to repair hearts; studying a Parkinson’s drug in …
FierceBiotech Researchers at Oxford University used gene therapy to reverse retinitis pigmentosa in mouse models of the disease, which is a common cause of blindness in young people. They delivered a gene that makes the light-sensing protein melanopsin to the … |
|
Incysus Seeks FDA Approval to Start Blood Cancer Trials for Its γδ T-Cell Immunotherapy
Lymphoma News Today Incysus has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) to start clinical development of its expanded and activated allogeneic gamma-delta (γδ) T-cell therapy for patients with blood cancers who … |
|
Incysus Seeks FDA Approval to Start Blood Cancer Trials for Its γδ T-Cell Immunotherapy
Lymphoma News Today Incysus has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) to start clinical development of its expanded and activated allogeneic gamma-delta (γδ) T-cell therapy for patients with blood cancers who … |